Scholl Hendrik Peter

Chief Medical OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2026Sell(S)2K$137.61$283K33K
Jun 16, 2026Sell(S)784$138.18$108K32K
Jun 16, 2026Sell(S)3K$139.57$438K29K
Jun 16, 2026Sell(S)540$140.58$76K28K
Jun 16, 2026Sell(S)100$141.83$14K28K
Jun 16, 2026Sell(S)450$142.20$64K28K
Jun 16, 2026Sell(S)2K$143.55$272K26K
Jun 16, 2026Sell(S)1K$145.02$150K25K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-273321) within minutes of acceptance. Every field above traces to the original document. Verify it directly: